Vir­ginia Rep. Span­berg­er asks FDA, DEA chiefs to re­spond to Adder­all short­ages

Adder­all has been get­ting hard­er to ob­tain and man­u­fac­ture — and now a Con­gress­woman wants an­swers from the FDA and the DEA.

Rep. Abi­gail Span­berg­er (D-VA), re-elect­ed to her third term in Con­gress last month, is ask­ing that the agen­cies ad­dress ques­tions re­lat­ed to pro­duc­tion quo­tas and to rem­e­dy an on­go­ing short­age of Adder­all to pa­tients who re­ly on it, ac­cord­ing to a let­ter to FDA Com­mis­sion­er Robert Califf and the DEA’s ac­tive ad­min­is­tra­tor Anne Mil­gram on Tues­day.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER